Search - tctmd.com

Displaying 41 - 57 of 57

Sort: Relevancy | Date

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

News Conference News ACC 2017

Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions

Shelley Wood

March 09, 2017

Presentation SIF 2017

Cardiac CTA for LAA Occlusion Planning and Follow Up

Presenter: Michael J. Rinaldi

March 08, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Daily News

Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients

Yael L. Maxwell

February 24, 2017

News Conference News CRT 2017

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

Michael O'Riordan

February 20, 2017

News Daily News

Minding the Gaps: Race and Sex Disparities in Rehospitalization Post-MI Might Be Due to Angina, Depression

Yael L. Maxwell

February 10, 2017

Presentation JIM 2017

CTO and Multi Vessel Disease. The key to complete revascularization

Presenter: Simon Walsh

February 09, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

News Daily News

LAA Thrombus Explored as Potential Cause of Stroke After TAVR

Todd Neale

January 16, 2017

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

News Industry News

Advertisement

Live From Washington: ACC 2017, Day Three

Live From Washington: ACC 2017, Day Two

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions

Cardiac CTA for LAA Occlusion Planning and Follow Up

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

Minding the Gaps: Race and Sex Disparities in Rehospitalization Post-MI Might Be Due to Angina, Depression

CTO and Multi Vessel Disease. The key to complete revascularization

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

LAA Thrombus Explored as Potential Cause of Stroke After TAVR

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content